Apolipoprotein E and low-density lipoprotein binding and internalization in primary cultures of rat astrocytes: Isoform-specific alterations

Journal of Neurochemistry

Volumn 66, Issue 6, 1996, Pages 2410-2418

  Guillaume, Daniel ^a,b   Bertrand, Philippe ^a   Dea, Doris ^a   Davignon, Jean ^d   Poirier, Judes ^a,b,c  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

Alzheimer's disease; Astrocyte; Cholesterol; CNS; Low density lipoprotein receptor; Plasticity

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; CHOLESTEROL; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; PHOSPHOLIPID; VERY LOW DENSITY LIPOPROTEIN;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; ASTROCYTE; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; GENE FREQUENCY; HIPPOCAMPUS; INTERNALIZATION; NERVE CELL CULTURE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RAT; REINNERVATION; SYNAPTOGENESIS;

ANIMALIA;

EID: 0029996997     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.66062410.x     Document Type: Article

References (49)

1. Alonzo R., Poirier J., O'Donnel D., Buisson N., Dorio J., and Boksa P. (1994) Statin, a marker of cell cycle arrest, is overexpressed during the early phase of delayed NMDA toxicity in hippocampal cell cultures. Mol. Cell. Neurosci. 5, 530-539.
2. Beffert U. and Poirier J. (1996) Apolipoprotein E, plaques, tangles and cholinergic dysfunction in Alzheimer's disease. Ann. NY Acad. Sci. 777, 166-174.
3. Beffert U., Aumont N., Davignon J., and Poirier J. (1995) Apolipoprotein E uptake is increased by beta-amyloid peptides and reduced by blockade of the LDL receptor in neurons. Soc. Neurosci. Abstr. 21, 1464.
4. Beisiegel U., Weber W., Ihrke G., Herz J., and Stanley K. K. (1989) The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein. Nature 341, 162-164.
5. Bertrand P., Poirier J., Oda T., Finch C. E., and Pasinetti G. M. (1995) Association between apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clusterin) in Alzheimer disease. Mol. Brain Res. 33, 174-178.
6. Blennow K., Hesse C., and Fredman P. (1994) Cerebrospinal fluid apolipoprotein E is reduced in Alzheimer's disease. Neuroreport 5, 2534-2536.
7. Boyles J. K., Zoellner C. D., Anderson L. J., Kosick L. M., Pitas R. E., Hui D. Y., Mahley R. W., Gebicke-Haerter P. J., Ignatius M. J., and Shooter E. M. (1989) A role for apolipoprotein E, apolipoprotein A-1, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. J. Clin. Invest. 83, 1015-1031.
8. Brissette L., Roach P. D., and Noel S.-P. (1986) The effects of liposome-reconstituted apolipoproteins on the binding of rat intermediate density lipoproteins to rat liver membranes. J. Biol. Chem. 261, 11631-11638.
9. Corder E. H., Saunders A. M., Strittmatter W. J., Schmechel D. E., Gaskell P. C., Small G. W., Roses A. D., Haines J. L., and Pericak-Vance M. A. (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921-923.
10. Davignon J., Gregg R. E., and Sing C. F. (1988) Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 8, 1-21.
11. Goldstein J. L., Basu S. K., Brunschede G. Y., and Brown M. S. (1976) Release of low density lipoprotein from its cell surface receptor by sulfated glycosaminoglycans. Cell 7, 85-95.
12. Goldstein J. L., Basu S. K., and Brown M. S. (1983) Receptor-mediated endocytosis of low-density lipoprotein in cultured cells. Methods Enzymol. 98, 241-261.
13. Gregg R. E., Zech L. A., and Schaefer E. J. (1986) Abnormal in vivo metabolism of apolipoprotein E4 in humans. J. Clin Invest. 78, 815-821.
14. Hara H. and Howard B. V. (1990) Characterization of LDL binding in TR 715-19 cells. Atherosclerosis 83, 155-165.
15. Innerarity T. L., Pitas R. E., and Mahley R. W. (1979) Binding of arginine-rich (E) apoprotein after recombination with phospholipid vesicles to the low density lipoprotein receptors of fibroblasts. J. Biol. Chem. 254, 4186-4190.
16. Innerarity T., Pitas R. E., and Mahley R. W. (1986) Lipoprotein-receptor interactions. Methods Enzmol. 129, 542-565.
17. Intebi A. D., Flaxman M. S., Ganong W. F., and Deschepper C. F. (1990) Angiotensinogen production by rat astroglial cells in vitro and in vivo. Neuroscience 34, 545-554.
18. Jung-Testas I., Weintraub H., Dupuis D., Eychenne B., Baulieu E.-E., and Robel P. (1992) Low density lipoprotein-receptors in primary cultures of rat glial cells. J. Steroid Biochem. Mol. Biol. 42, 597-605.
19. Kaufer J. N., Pettegrew J. W., Moossy J., and McCartney D. G. (1993) Alterations of selected enzymes of phospholipid metabolism in Alzheimer's disease brain tissue as compared to non-Alzheimer's demented controls. Neurochem. Res. 18, 331-334.
20. Kowal R. C., Herz J., Goldstein J. L., Esser V., and Brown M. S. (1989) Low density lipoprotein receptor-related protein mediates uptake of cholesterol esters derived from apoprotein E-enriched lipoproteins. Proc. Natl. Acad. Sci. USA 86, 5810-5814.
21. Ladu M. J., Falduto M. T., Manelli A. M., Reardon C. A., and Gertz G. S. (1994) Isoform specific binding of apolipoprotein E to β-amyloid. J. Biol. Chem. 269, 23403-23406.
22. Mahley R. W. (1988) Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240, 622-630.
23. Mahley R. W., Weisgraber K. H., and Innerarity T. L. (1979) Interactions of plasma lipoproteins containing apolipoproteins B and E with heparin and cell surface receptors. Biochim. Biophys. Acta 575, 81-91.
24. Masliah E., Mallory M., Alford M., and Muckle L. (1995) Abnormal synaptic regeneration in HAPP695 transgenic and apoE knockout mice, in Research Advances in Alzheimer's Disease and Related Disorders (Iqbal K., Mortimer J. A., Windblad B., and Wisniewski H., eds), in press. John Wiley and Son, New York.
25. Mason R. P., Shoemaker W. J., Shajenko L., Chambers T. E., and Herbette L. G. (1992) Evidence for changes in the Alzheimer's disease brain cortical membrane structure mediated by cholesterol. Neurobiol. Aging 13, 413-419.
26. Matz, C. E. and Jonas A. (1982) Reaction of human lecithin cholesterol acyltransferase with synthetic micellar complexes of apolipoprotein A1, phosphatidyl choline, and cholesterol. J. Biol. Chem. 257, 4535-4540.
27. Murakami M., Ushio Y., Mihara Y., Kuratsu J., Horiuchi S., and Morino Y. (1990) Cholesterol uptake by human glioma cells via receptor-mediated endocytosis of low-density lipoprotein. J. Neurosurg. 73, 760-767.
28. Payami H., Kaye J., Heston L. L., Bird T. D., and Schellenberg G. D. (1993) Apolipoprotein E genotype and Alzheimer's disease [letter]. Lancet 342, 738.
29. Pedreno J., de Castellarnau C., Cullare C., Sanchez J., Gomez-Gerique J., Ordonez-Llanos J., and Gonzalez-Sastre F. (1992) LDL binding sites on platelets differ from the "classical" receptor of nucleated cells. Arterioscler. Thromb. 12, 1353-1362.
30. Pitas R. E., Boyles J. K., Lee S. H., Foss D., and Mahley R. W. (1987a) Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. Biochim. Biophys. Acta 917, 148-161.
31. Pitas R. E., Boyles J. K., Lee S. H., Hui D., and Weisgraber K. H. (1987b) Lipoproteins and their receptors in the central nervous system. J. Biol. Chem. 262, 14352-14360.
32. Poirier J. (1994) Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci. 17, 525-530.
33. Poirier J., Hess M., May P. C., and Finch C. E. (1991) Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning. Mol. Brain Res. 11, 97-106.
34. Poirier J., Bertrand P., Alonzo R., Quirion R., and Boksa P. (1992) Neuronal cells in primary culture exhibit LDL receptor-mediated endocytosis of lipoproteins: a role in CNS cholesterol metabolism. Soc. Neurosci. Abstr. 18, 788.
35. Poirier J., Baccichet A., Dea D., and Gauthier S. (1993a) Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats. Neuroscience 55, 81-90.
36. Poirier J., Davignon J., Bouthillier D., Kogan S., Bertrand P., and Gauthier S. (1993b) Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 342, 697-699.
37. Poirier J., Delisle M. C., Quirion R., Aubert I., Rocheford J., Rousse I., Gracon S., Farlow S., and Gauthier S. (1996) Apolipoprotein E4, cholinergic integrity, synaptic plasticity and Alzheimer's disease, in Apolipoprotein E and Alzheimer's Disease (Roses A., Weisgraber K., and Christen Y., eds), in press. Springer-Verlag, Paris.
38. Rebeck G. W., Reiter J. S., Strickland D. K., and Hyman B. T. (1993) Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 11, 575-580.
39. Roheim P. S., Carey M., Forte T., and Vega G. L. (1979) Apolipoproteins in human cerebrospinal fluid. Proc. Natl. Acad. Sci. USA 76, 4646-4649.
40. Rudling M. J., Collins V. P., and Peterson C. O. (1983) Delivery of aclacinomycin A to human glioma cells in vitro by the low-density lipoprotein pathway. Cancer Res. 43, 4600-4605.
41. Salter A. M., Saxton J., and Brindley D. N. (1986) Characterization of the binding of human low-density lipoprotein to primary monolayer cultures of rat hepatocytes. Biochem. J. 240, 549-557.
42. Saunders A. M., Strittmatter W. J., Schmechel D., George-Hyslop P. H., Pericak-Vance M. A., Joo S. H., Rosi B. L., Gusella J. F., Crapper-MacLachlan D. R., and Alberts M. J. (1993) Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43, 1467-1472.
43. Schmechel D. E., Saunders A. M., Strittmatter W. J., Crain B. J., Bulette C. M., Joo S. H., Pericak-Vance M. A., Goldgaber D., and Roses A. D. (1993) Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer's disease. Proc. Natl. Acad. Sci. USA 90, 9649-9653.
44. Soininen H., Kosunen O., Helisalmi S., Mannermaa A., Paljarvi L., and Riekkinen O. (1995) Severe loss of choline acetyltransferase in the frontal cortex of Alzheimer's disease patients carrying apolipoprotein E4 allele. Neurosci. Lett. 187, 79-82.
45. Strittmatter W. J., Weisgraber K. H., Huang D. Y., Dong L. M., Salvesen G. S., Pericak-Vance M., Schmechel D., Saunders A. M., Goldgaber D., and Roses A. D. (1993) Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA 90, 8098-8102.
46. Swanson L. W., Simmons D. M., Hofmann S. L., Goldstein J. L., and Brown M. S. (1988) Localization of mRNA for low density lipoprotein receptor and a cholesterol synthetic enzyme in rabbit nervous system by in situ hybridization, Proc. Natl. Acad. Sci. USA 85, 9821-9825.
47. Takahashi S., Kawarabayasi Y., Nakait T., Sakai J., and Yamamoto T. (1992) Rabbit very low density lipoprotein receptor: a low density lipoprotein receptor-like protein with a distinct ligand specificity. Proc. Natl. Acad. Sci. USA 89, 9252-9256.
48. Utermann G. (1987) Apolipoprotein E polymorphism in health and disease. Am. Heart J. 113, 433-440.
49. Wurtman R. J. (1992) Choline metabolism as a basis for selective vulnerability of cholinergic neurons. Trends Neurosci. 15, 117-122.